Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Par Pharmaceutical Inc patents


Recent patent applications related to Par Pharmaceutical Inc. Par Pharmaceutical Inc is listed as an Agent/Assignee. Note: Par Pharmaceutical Inc may have other listings under different names/spellings. We're not affiliated with Par Pharmaceutical Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "P" | Par Pharmaceutical Inc-related inventors


Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

Peptide congeners with polymer excipients

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

07/06/17 / #20170189352

Epinephrine formulations

Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a ph raising agent, an antioxidant, a transition metal complexing agent, a ph lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.. ... Par Pharmaceutical Inc

06/15/17 / #20170165206

Epinephrine formulations

Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a ph raising agent, an antioxidant, a transition metal complexing agent, a ph lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.. ... Par Pharmaceutical Inc

06/08/17 / #20170157203

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

06/08/17 / #20170157202

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc

02/09/17 / #20170035853

Vasopressin formulations for use in treatment of hypotension

Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. ... Par Pharmaceutical Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Par Pharmaceutical Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Par Pharmaceutical Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###